NADPH oxidase 4 is an oncoprotein localized to mitochondria
- PMID: 20523116
- PMCID: PMC3040835
- DOI: 10.4161/cbt.10.3.12207
NADPH oxidase 4 is an oncoprotein localized to mitochondria
Abstract
Reactive oxygen species (ROS) are known to be involved in many physiological and pathological processes. Initially ROS-producing NADPH oxidase (NOX) proteins were thought to be present in phagocytes. However, recent studies have demonstrated that NOX proteins are expressed in many other cell types and tissues. NOX family members' expression and function seems to vary from tissue to tissue. We determined the expression of the NOX family of proteins (NOX1-5) in normal breast tissue and breast tumors. Our study revealed that normal breast tissues express NOX1, 4 and 5 genes. Similar pattern of expression was revealed in a breast epithelial cell line. We found that NOX4 was overexpressed in the majority of breast cancer cell lines and primary breast tumors. NOX4 was also overexpressed in ovarian tumors. Overexpression of NOX4 in normal breast epithelial cells resulted in cellular senescence, resistance to apoptosis, and tumorigenic transformation. Overexpression of NOX4 in already transformed breast tumor cells also showed increased tumorigenicity. Strong evidence suggests that regulation of these processes occurs through NOX4 generation of ROS in the mitochondria. We demonstrate that the NOX4 protein contains a 73 amino acid long mitochondrial localization signal at the N-terminus that is capable of transporting a passenger protein GFP into the mitochondria. Treatment of NOX4 overexpressing cells with catalase resulted in decreased tumorigenic characteristics. Together, this study provides evidence for an oncogenic function for NOX4 protein localized to mitochondria and suggests that NOX4 is a novel source of ROS produced in the mitochondria. This study also identifies a possible treatment of NOX4-induced breast cancer by antioxidant treatment.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3040835/bin/cbt1003_0223_fig001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3040835/bin/cbt1003_0223_fig002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3040835/bin/cbt1003_0223_fig003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3040835/bin/cbt1003_0223_fig004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3040835/bin/cbt1003_0223_fig005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3040835/bin/cbt1003_0223_fig006.gif)
Similar articles
-
NADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation.Int J Mol Sci. 2022 Feb 28;23(5):2702. doi: 10.3390/ijms23052702. Int J Mol Sci. 2022. PMID: 35269843 Free PMC article. Review.
-
Mammalian NADPH Oxidases.Methods Mol Biol. 2019;1982:17-36. doi: 10.1007/978-1-4939-9424-3_2. Methods Mol Biol. 2019. PMID: 31172464 Review.
-
ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis.Am J Physiol Cell Physiol. 2017 Jun 1;312(6):C749-C764. doi: 10.1152/ajpcell.00346.2016. Epub 2017 Apr 19. Am J Physiol Cell Physiol. 2017. PMID: 28424170 Free PMC article.
-
Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells.Br J Cancer. 2014 May 13;110(10):2569-82. doi: 10.1038/bjc.2014.165. Epub 2014 Apr 8. Br J Cancer. 2014. PMID: 24714748 Free PMC article.
-
Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors.Cancer Biol Ther. 2005 Dec;4(12):1367-73. doi: 10.4161/cbt.4.12.2233. Epub 2005 Dec 12. Cancer Biol Ther. 2005. PMID: 16294028
Cited by
-
Specific NOX4 Inhibition Preserves Mitochondrial Function and Dampens Kidney Dysfunction Following Ischemia-Reperfusion-Induced Kidney Injury.Antioxidants (Basel). 2024 Apr 19;13(4):489. doi: 10.3390/antiox13040489. Antioxidants (Basel). 2024. PMID: 38671936 Free PMC article.
-
Gene Expression and Prognostic Value of NADPH Oxidase Enzymes in Breast Cancer.Int J Mol Sci. 2024 Mar 19;25(6):3464. doi: 10.3390/ijms25063464. Int J Mol Sci. 2024. PMID: 38542437 Free PMC article.
-
Mitochondrial Dynamics in Pulmonary Hypertension.Biomedicines. 2023 Dec 25;12(1):53. doi: 10.3390/biomedicines12010053. Biomedicines. 2023. PMID: 38255160 Free PMC article. Review.
-
NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases.Neural Regen Res. 2024 Sep 1;19(9):1961-1966. doi: 10.4103/1673-5374.390973. Epub 2023 Dec 15. Neural Regen Res. 2024. PMID: 38227522 Free PMC article.
-
The NADPH Oxidase Inhibitor, Mitoapocynin, Mitigates DFP-Induced Reactive Astrogliosis in a Rat Model of Organophosphate Neurotoxicity.Antioxidants (Basel). 2023 Nov 30;12(12):2061. doi: 10.3390/antiox12122061. Antioxidants (Basel). 2023. PMID: 38136181 Free PMC article.
References
-
- Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4:23–24. - PubMed
-
- Banfi B, Tirone F, Durussel I, Knisz J, Moskwa P, Molnar GZ, et al. Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5) J Biol Chem. 2004;279:18583–18591. - PubMed
-
- Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005;109:217–226. - PubMed
-
- Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245–313. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical